Back
United Therapeutics Vs. AnaptysBio Industry Stock Comparison
Buy
55
UTHR
United Therapeutics
Last Price:
357.80
Seasonality Move:
2.3%
Buy
60
ANAB
AnaptysBio
Last Price:
34.83
Seasonality Move:
26.98%
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy, Sell or Hold?
- The current United Therapeutics [UTHR] share price is $355.59. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
AnaptysBio (ANAB)
is a Buy
Is AnaptysBio a Buy, Sell or Hold?
- The current AnaptysBio [ANAB] share price is $34.81. The Score for ANAB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- ANAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $355.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANAB Stock Price Chart
What is AnaptysBio's stock price today?
-
The AnaptysBio share price today is $34.81
The current trend is moderately bearish and ANAB is experiencing slight selling pressure.
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.22 | Buy |
| Relative Strength Index (14 RSI): | 59.98 | Buy |
| Chaikin Money Flow: | -192720 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.43 | Buy |
| Relative Strength Index (14 RSI): | 44.98 | Sell |
| Chaikin Money Flow: | -59843 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.73 - 38.23) | Sell |
| Bollinger Bands (100): | (24.6 - 36.04) | Buy |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 346.59 | Buy |
| 20-day SMA: | 349.56 | Buy |
| 50-day SMA: | 339.03 | Buy |
| 200-day SMA: | 271.32 | Buy |
| 8-day EMA: | 349.32 | Buy |
| 20-day EMA: | 346.8 | Buy |
| 50-day EMA: | 336.24 | Buy |
| 200-day EMA: | 287.83 | Buy |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.44 | Sell |
| 20-day SMA: | 36.91 | Sell |
| 50-day SMA: | 35.72 | Sell |
| 200-day SMA: | 26.39 | Buy |
| 8-day EMA: | 36.66 | Sell |
| 20-day EMA: | 36.64 | Sell |
| 50-day EMA: | 34.71 | Buy |
| 200-day EMA: | 27.93 | Buy |
United Therapeutics Earnings Growth & UTHR Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.87 per share, and an increase next year of $1.42 per share.
AnaptysBio Earnings Growth & ANAB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.65 per share, and a decrease next year of $0.06 per share.
United Therapeutics Technical Analysis
| Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AnaptysBio Technical Analysis
| Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||